Fulgent Genetics (NASDAQ:FLGT) is preparing to release its quarterly earnings on Friday, 2026-02-27. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Fulgent Genetics to report an earnings per share (EPS) of $-0.09.
The market awaits Fulgent Genetics’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings History Snapshot
Last quarter the company beat EPS by $0.50, which was followed by a 0.0% drop in the share price the next day.
Here’s a look at Fulgent Genetics’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.36 | -0.33 | -0.18 | -0.12 |
| EPS Actual | 0.14 | 0.07 | 0.04 | 0.04 |
| Price Change % | 18.15 | 7.86 | 19.07 | -1.53 |
Tracking Fulgent Genetics’s Stock Performance
Shares of Fulgent Genetics were trading at $23.56 as of February 25. Over the last 52-week period, shares are up 53.46%. Given that these returns are generally positive, long-term shareholders …